Ionis Pharmaceuticals, Inc. Income Taxes Paid
Ionis Pharmaceuticals, Inc. (IONS) reported Income Taxes Paid of $2.07 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2024-11-06
- Ionis Pharmaceuticals, Inc. income taxes paid for the quarter ending 2024-09-30 was $80.00K, a 60.78% decline year-over-year.
- Ionis Pharmaceuticals, Inc. income taxes paid for the quarter ending 2024-06-30 was $1.98M, a 811.98% increase year-over-year.
- Ionis Pharmaceuticals, Inc. income taxes paid for the quarter ending 2024-03-31 was $13.00K, a 95.56% decline year-over-year.
- Ionis Pharmaceuticals, Inc. income taxes paid for the quarter ending 2023-12-31 was $47.62M, a 850.88% increase year-over-year.
- Ionis Pharmaceuticals, Inc. income taxes paid for fiscal 2023 was $48.33M, a 864.75% increase from fiscal 2022.
- Ionis Pharmaceuticals, Inc. income taxes paid for fiscal 2022 was $5.01M, a 13084.21% increase from fiscal 2021.
- Ionis Pharmaceuticals, Inc. income taxes paid for fiscal 2021 was $38.00K, a 99.85% decline from fiscal 2020.
- Ionis Pharmaceuticals, Inc. income taxes paid for fiscal 2020 was $25.86M, a 185.98% increase from fiscal 2019.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 6 month | Income Taxes Paid 9 month | Income Taxes Paid 12 month |
|---|---|---|---|---|
| 2024-09-30 | $80.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $2.06M derived: sum of 2 quarters · filed 2024-11-06 | $2.07M 10-Q · filed 2024-11-06 | $49.69M derived: sum of 4 quarters · filed 2024-11-06 |
| 2024-06-30 | $1.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $1.99M 10-Q · filed 2024-08-01 | $49.61M derived: sum of 3 quarters · filed 2024-08-01 | $49.82M derived: sum of 4 quarters · filed 2024-11-06 |
| 2024-03-31 | $13.00K 10-Q · filed 2024-05-07 | $47.63M derived: sum of 2 quarters · filed 2024-05-07 | $47.84M derived: sum of 3 quarters · filed 2024-11-06 | $48.05M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-12-31 | $47.62M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $47.82M derived: sum of 2 quarters · filed 2024-11-06 | $48.04M derived: sum of 3 quarters · filed 2024-11-06 | $48.33M 10-K · filed 2024-02-21 |
| 2023-09-30 | $204.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $421.00K derived: sum of 2 quarters · filed 2024-11-06 | $714.00K 10-Q · filed 2024-11-06 | $5.72M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $217.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $510.00K 10-Q · filed 2024-08-01 | $5.52M derived: sum of 3 quarters · filed 2024-08-01 | $5.52M derived: sum of 4 quarters · filed 2024-08-01 |
| 2023-03-31 | $293.00K 10-Q · filed 2024-05-07 | $5.30M derived: sum of 2 quarters · filed 2024-05-07 | $5.30M derived: sum of 3 quarters · filed 2024-05-07 | $5.30M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $5.01M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $5.01M derived: sum of 2 quarters · filed 2024-02-21 | $5.01M derived: sum of 3 quarters · filed 2024-02-21 | $5.01M 10-K · filed 2024-02-21 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $0.00 derived: sum of 2 quarters · filed 2023-11-02 | $2.00K 10-Q · filed 2023-11-02 | $37.00K derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $2.00K 10-Q · filed 2023-08-09 | $37.00K derived: sum of 3 quarters · filed 2024-02-21 | $40.00K derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $2.00K 10-Q · filed 2023-05-03 | $37.00K derived: sum of 2 quarters · filed 2024-02-21 | $40.00K derived: sum of 3 quarters · filed 2024-02-21 | $38.00K derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $38.00K derived: sum of 2 quarters · filed 2024-02-21 | $36.00K derived: sum of 3 quarters · filed 2024-02-21 | $38.00K 10-K · filed 2024-02-21 |
| 2021-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $1.00K derived: sum of 2 quarters · filed 2022-11-09 | $3.00K 10-Q · filed 2022-11-09 | $2.33M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | $2.32M derived: sum of 3 quarters · filed 2023-02-22 | $25.81M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | $2.00K 10-Q · filed 2022-05-04 | $2.33M derived: sum of 2 quarters · filed 2023-02-22 | $25.81M derived: sum of 3 quarters · filed 2023-02-22 | $25.85M derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | $2.32M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $25.81M derived: sum of 2 quarters · filed 2023-02-22 | $25.85M derived: sum of 3 quarters · filed 2023-02-22 | $25.86M 10-K · filed 2023-02-22 |
| 2020-09-30 | $23.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $23.53M derived: sum of 2 quarters · filed 2021-11-03 | $23.53M 10-Q · filed 2021-11-03 | $23.54M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $46.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $49.00K 10-Q · filed 2020-08-05 | $53.00K derived: sum of 3 quarters · filed 2022-02-25 | $9.09M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $3.00K 10-Q · filed 2021-05-05 | $7.00K derived: sum of 2 quarters · filed 2022-02-25 | $9.04M derived: sum of 3 quarters · filed 2022-02-25 | $9.04M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $9.04M derived: sum of 2 quarters · filed 2022-02-25 | $9.04M derived: sum of 3 quarters · filed 2022-02-25 | $9.04M 10-K · filed 2022-02-25 |
| 2019-09-30 | $9.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $9.04M derived: sum of 2 quarters · filed 2020-11-04 | $9.04M 10-Q · filed 2020-11-04 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $0.00 10-Q · filed 2020-08-05 | ||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-06 | |||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |